Skip to Content

Join the 'Skin Cancer' group to help and get support from people like you.

Skin Cancer News

Related terms: Cancer, Skin

Majority of Americans and Canadians Expects Cancer Cure in Their Lifetime

Posted 7 days ago by Drugs.com

THURSDAY, Feb. 4, 2016 – A majority of American and Canadian adults believe a cure for cancer will be found in their lifetime, and that a cancer diagnosis is not a death sentence, according to a new Harris Poll. Nearly three out of five Americans and Canadians expect a cure for cancer in their lifetime. That belief is especially strong among those ages 18 to 34. Nearly three-quarters of young Americans and 69 percent of Canadians in that age group expect a cure in their lifetime. And, about two-thirds of Americans and Canadians don't think death is inevitable when someone is diagnosed with cancer, the poll found. However, Americans adults under 35 are more likely to believe that a cancer diagnosis is a death sentence than those 35 and older (39 percent vs. 29 percent). Americans whose lives have been affected by cancer are also more likely to view cancer as deadly compared to those who ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer, Breast Cancer - Palliative, Testicular Cancer, Solid Tumors, Urinary Tract Cancer

Melanoma Strikes Earlier If Indoor Tanning Begins in Teens: Study

Posted 15 days ago by Drugs.com

WEDNESDAY, Jan. 27, 2016 – Using tanning beds at a young age significantly raises a woman's risk of developing melanoma before the age of 50, a new study finds. A study of adults ages 25 to 49 found the risk for the deadly skin cancer increased two to six times for women who tanned indoors, with the greatest odds seen for those who used tanning beds in their teens and 20s. "All women who use indoor tanning are at risk of melanoma, but the strongest risk was among women who tanned in their 20s, who were about six times more likely to develop the disease, compared to women who didn't tan indoors," said lead researcher DeAnn Lazovich, an associate professor of epidemiology and community health at the University of Minnesota. The findings support a recent U.S. Food and Drug Administration proposal to ban indoor tanning before age 18, Lazovich said. However, she added, "we need to do even ... Read more

Related support groups: Melanoma, Skin Cancer, Melanoma - Metastatic, History - Skin Cancer

During Pregnancy, Skin Cancer May Be Deadlier: Study

Posted 21 Jan 2016 by Drugs.com

WEDNESDAY, Jan. 20, 2016 – Women diagnosed with melanoma skin cancer during or just after pregnancy are at greater risk from the cancer than other women, a new study finds. Pregnancy hormones may fuel the most deadly type of skin cancer, the researchers said. "The rate of metastasis (cancer spread), recurrence and death in our findings were astounding – as the rates were measurably higher in women who were diagnosed with melanoma while pregnant, or within one year after delivery," lead investigator Dr. Brian Gastman, a plastic surgeon and director of melanoma surgery at the Cleveland Clinic, said in a hospital news release. However, the study was only designed to find a link between melanoma outcomes and pregnancy; it cannot show a cause-and-effect relationship. The study looked at almost 500 women diagnosed with melanoma between 1988 and 2012. The women were aged 49 or younger. The ... Read more

Related support groups: Birth Control, Contraception, Emergency Contraception, Postcoital Contraception, Basal Cell Carcinoma, Melanoma, Skin Cancer, Melanoma - Metastatic, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Squamous Cell Carcinoma, History - Skin Cancer

Terminal Cancer Patients in U.S. Less Likely to Die in Hospitals

Posted 19 Jan 2016 by Drugs.com

TUESDAY, Jan. 19, 2016 – Comparing end-of-life practices internationally, researchers found the United States has the lowest percentage of in-hospital cancer deaths among seven developed countries. Terminally ill U.S. cancer patients also spend less time in the hospital the last six months of life than those in the other countries, although they are more likely to receive intensive care and chemotherapy, researchers found. The study, published in the Jan. 19 issue of the Journal of the American Medical Association, suggests that end-of-life care has changed significantly in response to patient preferences. "In the early 1980s, more than 70 percent of U.S. cancer patients died in hospital," wrote Dr. Ezekiel Emanuel, of the University of Pennsylvania's Perelman School of Medicine, and colleagues. Over the last 30 years, the researchers said, several factors have helped advance ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Melanoma, Skin Cancer, Cervical Cancer, Bladder Cancer, Stomach Cancer, Solid Tumors, History - Skin Cancer, Urinary Tract Cancer

Families Say Hospice Better Than Hospital for Dying Cancer Patients

Posted 19 Jan 2016 by Drugs.com

TUESDAY, Jan. 19, 2016 – Families of patients dying of cancer felt their loved one had better care and quality of life when they died in a hospice rather than in a hospital's intensive care unit, a new study reveals. Relatives reported a better end-of-life experience more often when their loved one received hospice care for more than three days (59 percent) than those who received hospice care for three or fewer days (43 percent). Moreover, only 45 percent of families reported excellent care when the patient was admitted to a hospital intensive care unit (ICU) within 30 days of dying, the researchers found. "Our findings are a powerful argument for the importance of advance care planning," said lead researcher Dr. Alexi Wright, an associate professor of medicine at Harvard Medical School in Boston. How and where people die strongly shapes patients' dying experience and how family ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Melanoma, Skin Cancer, Endometrial Cancer, Bladder Cancer, Head and Neck Cancer, Gastric Cancer, Breast Cancer - Palliative

Some Families Carry Shared Risk of Cancer, Twins Study Shows

Posted 5 Jan 2016 by Drugs.com

TUESDAY, Jan. 5, 2016 – A new study of twins has shed light on the shared roles of genetics and environment in determining a person's risk of cancer. Having an identical twin diagnosed with cancer increases the other twin's risk of developing not just that type but any form of cancer, said lead researcher Lorelei Mucci, an associate professor of epidemiology at the Harvard T.H. Chan School of Public Health in Boston. This suggests that some families carry a shared increased risk for any type of cancer, based on their genes, she said. "Different cancers may share an inherited susceptibility based on genetic factors," Mucci said. "This is an area that we're just learning about." However, the influence of genetics varies widely depending on the type of cancer, Mucci added. For example, testicular, skin and prostate cancers were shown to be influenced strongly by genetics, while lung, ... Read more

Related support groups: Prostate Cancer, Lung Cancer, Colorectal Cancer, Skin Cancer, Testicular Cancer

FDA Proposes Tanning Bed Age Restrictions and Other Important Safety Measures

Posted 21 Dec 2015 by Drugs.com

December 18, 2015 – Today, the U.S. Food and Drug Administration announced important proposed steps ‎to protect public health by preventing the use of sunlamp products (also commonly known as indoor tanning beds) by minors and reducing the risk of using these devices for adults. The FDA is committed to protecting public health by informing consumers of the risks of indoor tanning. “Today’s action is intended to help protect young people from a known and preventable cause of skin cancer and other harms,” said acting FDA Commissioner Stephen Ostroff, M.D. “Individuals under 18 years are at greatest risk of the adverse health consequences of indoor tanning.” Indoor tanning is a known contributor to skin cancer, including melanoma (its most deadly form), and other skin damage. Yet, 1.6 million minors indoor tan each year, increasing their risk of skin cancer and other damage (based on dat ... Read more

Related support groups: Skin Cancer

FDA Proposes Tanning Bed Ban for Minors

Posted 18 Dec 2015 by Drugs.com

FRIDAY, Dec. 18, 2015 – The U.S. Food and Drug Administration on Friday proposed that American teenagers be banned from using tanning beds. "Today's action is intended to help protect young people from a known and preventable cause of skin cancer and other harms," acting FDA Commissioner Dr. Stephen Ostroff said in a statement. "Individuals under 18 are at greatest risk of the adverse health consequences of indoor tanning." The proposal also would require users 18 and older to sign a document that says they are aware of the health risks posed by tanning beds. They would have to sign the document before their first indoor tanning session and every six months after that, the agency said. "The FDA understands that some adults may decide to continue to use sunlamp products," Ostroff said. "These proposed rules are meant to help adults make their decisions based on truthful information, and ... Read more

Related support groups: Basal Cell Carcinoma, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, History - Skin Cancer

Suspicious Pigment Spots More Common on Darker Skin

Posted 14 Dec 2015 by Drugs.com

MONDAY, Dec. 14, 2015 – People with darker skin are about one-third more likely to have potentially dangerous pigment "spots" on their palms and soles, a new study finds. In rare cases, these "acral pigmented lesions" turn out to be melanoma skin cancer. People with these lesions should have them checked by a dermatologist to be sure they are benign, the researchers said. Reggae musician Bob Marley, for example, died from acral melanoma, which was diagnosed under his toenail. "Acral pigmented lesions have not been well studied in people with darker skin," senior study author Dr. Jennifer Stein, an associate professor in the department of dermatology at NYU Langone Medical Center in New York City, said in a center news release. Stein's team evaluated the palms and soles of 1,052 patients seen at dermatology clinics in New York City and Miami. The researchers detected 391 acral pigmented ... Read more

Related support groups: Basal Cell Carcinoma, Sunburn, Skin and Structure Infection, Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, Photoaging of the Skin, Dermatoheliosis, History - Skin Cancer, Minor Skin Conditions, Scrapes, Prevention of Sunburn

Retail Prices of Dermatology Drugs Skyrocket

Posted 25 Nov 2015 by Drugs.com

WEDNESDAY, Nov. 25, 2015 – Patients using prescription creams, gels, sprays and pills for skin conditions may shell out substantially more at the pharmacy than they did just six years ago, a new study suggests. Between 2009 and 2015, retail prices of brand-name dermatologic drugs rose 401 percent, on average, study authors reported Nov. 25 in JAMA Dermatology. Even generics have succumbed to price inflation, up 279 percent between 2011 and 2014, based on the drugs surveyed. Price increases for skin treatments far outpaced the general inflation rate of 11 percent during the six-year study period, the researchers said. "Cancer drugs were the worst in terms of the numbers" – up 1,240 percent or nearly $11,000 over the six-year study period – primarily because of two medicines, said Dr. Steven Rosenberg, voluntary professor of dermatology at the University of Miami Miller School of ... Read more

Related support groups: Monistat, RID, Eczema, Monistat 3, Voltaren Gel, Dermatitis, Bactroban, Contact Dermatitis, Therapeutic, Clobetasol, Mupirocin, Hypercare, Maintain, Monistat 7, Fluocinonide, Sulfur, Retin-A, Lidoderm, Silver, Efudex

FDA Approves Yervoy to Reduce the Risk of Melanoma Returning after Surgery

Posted 28 Oct 2015 by Drugs.com

October 28, 2015 – Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery. Melanoma, the most aggressive type of skin cancer, is the leading cause of death from skin cancer. Melanoma is more likely to spread to other parts of the body than other forms of skin cancer and has been on the rise over the past several decades, according to the National Cancer Institute, with an estimated 73,870 new cases and 9,940 deaths from the disease this year. In stage III melanoma, the cancer has reached one or more lymph nodes. Patients with stage III melanoma are generally treated by surgery to remove the melanoma skin lesions and the nearby lymph nodes. “Today’s approval of Yervoy extends its use to patients who are at ... Read more

Related support groups: Melanoma, Skin Cancer, Melanoma - Metastatic, Yervoy, Ipilimumab

FDA Approves Imlygic (talimogene laherparepvec) for the Treatment of Melanoma

Posted 28 Oct 2015 by Drugs.com

October 27, 2015 – The U.S. Food and Drug Administration today approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the skin and lymph nodes. “Melanoma is a serious disease that can advance and spread to other parts of the body, where it becomes difficult to treat,” said Karen Midthun, M.D., director of the FDA’s Center for Biologics Evaluation and Research. “This approval provides patients and health care providers with a novel treatment for melanoma.” Skin cancer is the most common form of cancer in the United States. Melanoma, one type of skin cancer, is the leading cause of skin cancer related deaths, and is most often caused by exposure to ultraviolet (UV) light. According to the National Cancer Institute approximately 74,000 Americans will be diagnosed with melanoma and nearly 10,000 will die from t ... Read more

Related support groups: Melanoma, Skin Cancer, Melanoma - Metastatic, Imlygic, Talimogene Laherparepvec

B Vitamin May Help Ward Off Some Skin Cancers

Posted 21 Oct 2015 by Drugs.com

WEDNESDAY, Oct. 21, 2015 – A cheap and readily available vitamin supplement appears to reduce a person's risk of some skin cancers, a new clinical trial indicates. A form of vitamin B3 called nicotinamide appears to reduce non-melanoma skin cancers by 23 percent when taken twice daily, the Australian researchers reported. "It's safe, it's almost obscenely inexpensive and it's already widely commercially available," said senior study author Dr. Diona Damian, a professor of dermatology at the University of Sydney. Nicotinamide costs less than $10 for a month's supply and is available at pharmacies and health food stores, she said. However, more study is needed before researchers can say whether everyone would benefit from the supplement. "It's not something we'd recommend at this stage for the general population," Damian said. Skin cancer is the most common form of cancer in the United ... Read more

Related support groups: Basal Cell Carcinoma, Melanoma, Skin Cancer, Squamous Cell Carcinoma, History - Skin Cancer, Nicotinamide, Nicomide-T

Count the Moles on Your Arm to Predict Melanoma Risk?

Posted 20 Oct 2015 by Drugs.com

MONDAY, Oct. 19, 2015 – Having 11 moles or more on your right arm might indicate higher risk of melanoma, British researchers say. The study results could help doctors more easily identify patients at highest risk for the potentially deadly skin cancer, according to researchers from King's College London. "The findings could have a significant impact for primary care, allowing [primary care doctors] to more accurately estimate the total number of moles in a patient extremely quickly via an easily accessible body part. This would mean that more patients at risk of melanoma can be identified and monitored," study lead author Simone Ribero, of the department of twin research and genetic epidemiology, said in a college news release. Between 20 percent and 40 percent of melanomas develop from pre-existing moles, the researchers said. The risk is thought to increase slightly with each ... Read more

Related support groups: Melanoma, Skin Cancer, Melanoma - Metastatic, History - Skin Cancer

Many Skin Cancer Patients Skip Routine Self-Exams

Posted 16 Oct 2015 by Drugs.com

FRIDAY, Oct. 16, 2015 – Many people who've had melanoma skin cancer don't regularly check their skin for new or recurring signs of cancer, a new study reveals. Routine skin self-exams are critical to ensure the early detection of new or recurring skin cancer, but the study found that fewer than 15 percent of melanoma patients consistently perform thorough skin self-exams. "The most common reasons given for not having conducted such an exam over the prior two-month period were that patients didn't think of it, didn't know what to look for, or didn't know that they should," the study's lead author, Elliot Coups, a behavioral scientist at Rutgers Cancer Institute of New Jersey, said in an institute news release. The study included 176 people who'd had malignant melanoma, the most serious form of skin cancer. More than half of the study volunteers were women, and 99 percent were white, the ... Read more

Related support groups: Melanoma, Skin Cancer, Melanoma - Metastatic, Squamous Cell Carcinoma, Diagnosis and Investigation, History - Skin Cancer

Page 1 2 3 4 5 6 7 8 9 Next

Ask a Question

Further Information

Related Condition Support Groups

Basal Cell Carcinoma, Melanoma, Squamous Cell Carcinoma, History - Skin Cancer, Cancer

Related Drug Support Groups

Efudex, Carac, Fluoroplex, Efudex Occlusion Pack